These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anti-Proteinase 3 Antibodies as a Biomarker for Ulcerative Colitis and Primary Sclerosing Cholangitis in Children. Laass MW; Ziesmann J; de Laffolie J; Röber N; Conrad K J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):463-470. PubMed ID: 35703948 [TBL] [Abstract][Full Text] [Related]
4. C-ANCA/proteinase 3-positive colitis in children: a distinctive form of inflammatory bowel disease or vasculitis with colitis as initial presentation? Van Biervliet S; Bonroy C; Vande Velde S; De Bruyne R; Van Winckel M; Peeters H; Delanghe J; Stove V; De Vos M J Pediatr Gastroenterol Nutr; 2013 Oct; 57(4):489-92. PubMed ID: 23752080 [TBL] [Abstract][Full Text] [Related]
5. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study. Desplat-Jégo S; Johanet C; Escande A; Goetz J; Fabien N; Olsson N; Ballot E; Sarles J; Baudon JJ; Grimaud JC; Veyrac M; Chamouard P; Humbel RL World J Gastroenterol; 2007 Apr; 13(16):2312-8. PubMed ID: 17511029 [TBL] [Abstract][Full Text] [Related]
6. Clinical indications of the use of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in the evaluation of inflammatory bowel disease at an Academic Medical Center. Gupta A; Derbes C; Sellin J Inflamm Bowel Dis; 2005 Oct; 11(10):898-902. PubMed ID: 16189419 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases. Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of perinuclear antineutrophil cytoplasmic antibodies in subjects with primary sclerosing cholangitis. Guglielmi V; Giorgio P; Guerra V; Sonnante A; Tutino M; Donghia R; Pisani A Minerva Med; 2022 Jun; 113(3):513-517. PubMed ID: 32407046 [TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis. Dobric S; Popovic D; Nikolic M; Andrejevic S; Spuran M; Bonaci-Nikolic B Clin Chem Lab Med; 2011 Nov; 50(3):503-9. PubMed ID: 22107137 [TBL] [Abstract][Full Text] [Related]
20. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Stoffel MP; Csernok E; Herzberg C; Johnson T; Carroll SF; Gross WL Clin Exp Immunol; 1996 Apr; 104(1):54-9. PubMed ID: 8603534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]